Targeted therapies and predictive markers in epithelial malignancies of the gastrointestinal tract.


CONTEXT In recent years, there has been a tremendous amount of interest in the development of targeted therapies for the treatment of human cancers. Increased understanding of the specific molecular pathways and driver mutations critical to cancer cell growth have allowed the development of these advanced therapeutics. Among these, inhibitors of the… (More)
DOI: 10.5858/arpa.2011-0167-RA


2 Figures and Tables